BibTex RIS Kaynak Göster

The use of levofloxacin in a patient with leptospirosis

Yıl 2006, Cilt: 8 Sayı: 1, 14 - 15, 01.03.2006

Davut Ozdemir İrfan Sencan Tevfik Yavuz Oguz Karabay Ertugrul Guclu

Kaynakça

  • Shalit I, Barnea A, Shahar A: Efficacy of ciprofloxacin againts interrogans serogroup icterohaemorrhagiae. Antimicrob Agents Chemother. 33: 788-789, 1989. Leptospira
  • Sünbül M: Leptospiroz. ANKEM Derg. 20 (Ek2): 219-221, 2006.
  • Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM: Leptospirosis: a zoonotic disease of globalimportance. Lancet Infect Dis . 3: 757–771, 2003.
  • http://www.med.monash.edu.au/microbiol ogy/staff/adler/leptoguidelines2003pdf
  • Takashima I, Ngoma M, Hashimoto N: Antimicrobial effects of a new carboxyquinolone drug, Q-35, on five serogroups of Leptospira interrogans. Antimicrob Agents Chemother. 37: 901- 902, 1993.
  • Truccola J, Charavay F, Merien F, Perolat P: Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother. 46: 848- 852, 2002.
  • Schonberg A: Studies on the effect of antibiotic substances on leptospires and their cultivation from material with a high bacterial count. Zentralbl Bacteriol A. 249: 400-406, 1981.
  • Sugunan AP, Natarajaseenivasan K, Vijayachari P, Seghal SC: Percutaneous exposure resulting in laboratory-acquired leptospirosis -a case report. J Med Microbiol. 53: 1258-1262, 2004.
  • Mancel E, Merrien F, Pesenti L, Salino D, Angibaud G, Perolat P: Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific). Aust N Z J Ophthalmol. 27: 380– 386, 1999.
  • National Committee for Clinical Laboratory Standards: dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa,1997.

The use of levofloxacin in a patient with leptospirosis

Yıl 2006, Cilt: 8 Sayı: 1, 14 - 15, 01.03.2006

Davut Ozdemir İrfan Sencan Tevfik Yavuz Oguz Karabay Ertugrul Guclu

Kaynakça

  • Shalit I, Barnea A, Shahar A: Efficacy of ciprofloxacin againts interrogans serogroup icterohaemorrhagiae. Antimicrob Agents Chemother. 33: 788-789, 1989. Leptospira
  • Sünbül M: Leptospiroz. ANKEM Derg. 20 (Ek2): 219-221, 2006.
  • Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM: Leptospirosis: a zoonotic disease of globalimportance. Lancet Infect Dis . 3: 757–771, 2003.
  • http://www.med.monash.edu.au/microbiol ogy/staff/adler/leptoguidelines2003pdf
  • Takashima I, Ngoma M, Hashimoto N: Antimicrobial effects of a new carboxyquinolone drug, Q-35, on five serogroups of Leptospira interrogans. Antimicrob Agents Chemother. 37: 901- 902, 1993.
  • Truccola J, Charavay F, Merien F, Perolat P: Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother. 46: 848- 852, 2002.
  • Schonberg A: Studies on the effect of antibiotic substances on leptospires and their cultivation from material with a high bacterial count. Zentralbl Bacteriol A. 249: 400-406, 1981.
  • Sugunan AP, Natarajaseenivasan K, Vijayachari P, Seghal SC: Percutaneous exposure resulting in laboratory-acquired leptospirosis -a case report. J Med Microbiol. 53: 1258-1262, 2004.
  • Mancel E, Merrien F, Pesenti L, Salino D, Angibaud G, Perolat P: Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific). Aust N Z J Ophthalmol. 27: 380– 386, 1999.
  • National Committee for Clinical Laboratory Standards: dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa,1997.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Editöryal
Yazarlar

Davut Ozdemir Bu kişi benim

İrfan Sencan Bu kişi benim

Tevfik Yavuz Bu kişi benim

Oguz Karabay Bu kişi benim

Ertugrul Guclu Bu kişi benim

Yayımlanma Tarihi 1 Mart 2006
Yayımlandığı Sayı Yıl 2006 Cilt: 8 Sayı: 1

Kaynak Göster

APA Ozdemir, D., Sencan, İ., Yavuz, T., Karabay, O., vd. (2006). The use of levofloxacin in a patient with leptospirosis. Duzce Medical Journal, 8(1), 14-15.
AMA Ozdemir D, Sencan İ, Yavuz T, Karabay O, Guclu E. The use of levofloxacin in a patient with leptospirosis. Duzce Med J. Mart 2006;8(1):14-15.
Chicago Ozdemir, Davut, İrfan Sencan, Tevfik Yavuz, Oguz Karabay, ve Ertugrul Guclu. “The Use of Levofloxacin in a Patient With Leptospirosis”. Duzce Medical Journal 8, sy. 1 (Mart 2006): 14-15.
EndNote Ozdemir D, Sencan İ, Yavuz T, Karabay O, Guclu E (01 Mart 2006) The use of levofloxacin in a patient with leptospirosis. Duzce Medical Journal 8 1 14–15.
IEEE D. Ozdemir, İ. Sencan, T. Yavuz, O. Karabay, ve E. Guclu, “The use of levofloxacin in a patient with leptospirosis”, Duzce Med J, c. 8, sy. 1, ss. 14–15, 2006.
ISNAD Ozdemir, Davut vd. “The Use of Levofloxacin in a Patient With Leptospirosis”. Duzce Medical Journal 8/1 (Mart 2006), 14-15.
JAMA Ozdemir D, Sencan İ, Yavuz T, Karabay O, Guclu E. The use of levofloxacin in a patient with leptospirosis. Duzce Med J. 2006;8:14–15.
MLA Ozdemir, Davut vd. “The Use of Levofloxacin in a Patient With Leptospirosis”. Duzce Medical Journal, c. 8, sy. 1, 2006, ss. 14-15.
Vancouver Ozdemir D, Sencan İ, Yavuz T, Karabay O, Guclu E. The use of levofloxacin in a patient with leptospirosis. Duzce Med J. 2006;8(1):14-5.
Creative Commons Lisansı
Düzce Tıp Fakültesi Dergisi Creative Commons Atıf-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.